Innocoll Pharms Company Profile
What is the competitive landscape for INNOCOLL PHARMS
INNOCOLL PHARMS has one approved drug.
There are two US patents protecting INNOCOLL PHARMS drugs.
Summary for Innocoll Pharms
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Innocoll Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innocoll Pharms | XARACOLL | bupivacaine hydrochloride | IMPLANT;IMPLANTATION | 209511-001 | Aug 28, 2020 | DISCN | Yes | No | RE47826 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Innocoll Pharms | XARACOLL | bupivacaine hydrochloride | IMPLANT;IMPLANTATION | 209511-001 | Aug 28, 2020 | DISCN | Yes | No | 11,746,141 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Innocoll Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Turkey | 201907156 | ⤷ Start Trial |
| San Marino | T202100257 | ⤷ Start Trial |
| Turkey | 201905174 | ⤷ Start Trial |
| Lithuania | 3255106 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2008117268 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
